- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04004143
Micronutrients and Health in Adult Chinese
June 27, 2019 updated by: Zhou Ji-Chang, Shenzhen Center for Chronic Disease Control
Adult subjects were recruited from a health examination center.
Their fasting blood samples were collected for laboratory analyses of multiple measures including mineral, glucose, lipids, etc.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Actual)
1520
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
20 years to 85 years (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
Adult volunteers visiting a health examination center were randomly recruited with their consent to particiapate the study.
Description
Inclusion Criteria:
- adult volunteer
- Han population
- living in Shenzhen City for > 2 y
Exclusion Criteria:
- caught by organic diseases
- in pregnancy
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Cross-sectional
a cross-sectional study.
|
No intervention.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
circulation concentration of glucose
Time Frame: less than 4 hours
|
Glucose (mmol/L) was measured in less than 4 hours after sample collection
|
less than 4 hours
|
|
circulation concentrations of 4 types of lipids
Time Frame: less than 4 hours
|
TG, TC, LDLC, and HDLC (mmol/L) were measured in less than 4 hours after sample collection
|
less than 4 hours
|
|
circulation concentrations of 5 minerals
Time Frame: less than 3 years
|
all samples were stored at minus 75 degrees Celsius until ready for analysis collectively on a ICP-MS machine for calcium, cobalt, iron, selenium, and zinc (ng/ml)
|
less than 3 years
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
body mass index
Time Frame: less than 1 month
|
body weight (kg) and hight (m) were measured when the volunteers were visiting the health examination center, and the body mass index was calculated later by the formula of body weight/ hight/ hight (kg/m^2).
|
less than 1 month
|
|
circulation concentration of 25OHD
Time Frame: less than 3 years
|
all samples were stored at minus 75 degrees Celsius until ready for analysis collectively with ELISA kits (nmol/L)
|
less than 3 years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
August 1, 2013
Primary Completion (Actual)
November 30, 2013
Study Completion (Actual)
December 31, 2014
Study Registration Dates
First Submitted
June 26, 2019
First Submitted That Met QC Criteria
June 27, 2019
First Posted (Actual)
July 1, 2019
Study Record Updates
Last Update Posted (Actual)
July 1, 2019
Last Update Submitted That Met QC Criteria
June 27, 2019
Last Verified
June 1, 2019
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- QLS2014
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Dyslipidemia
-
Chong Kun Dang PharmaceuticalCompletedDyslipidemia (Fredrickson Type Ⅱa) | Dyslipidemia (Fredrickson Type Ⅱb)Korea, Republic of
-
Kowa Research Institute, Inc.CompletedMixed Dyslipidemia | Primary DyslipidemiaUnited States
-
Fundación del Caribe para la Investigación BiomédicaNaturmegaNot yet recruitingMixed DyslipidemiaColombia
-
Addpharma Inc.Not yet recruitingMixed DyslipidemiaSouth Korea
-
Daewon Pharmaceutical Co., Ltd.Completed
-
Addpharma Inc.RecruitingMixed DyslipidemiaKorea, Republic of
-
Hanlim Pharm. Co., Ltd.RecruitingMixed DyslipidemiaKorea, Republic of
-
IlDong Pharmaceutical Co LtdNot yet recruiting
-
Arrowhead PharmaceuticalsCompletedMixed DyslipidemiaUnited States, Australia, Canada, Hungary, New Zealand, Poland
-
Shanghai Argo Biopharmaceutical Co., Ltd.Active, not recruiting
Clinical Trials on No intervention
-
Hopital FochNot yet recruitingInterstitial Lung DiseaseFrance
-
Wave NeuroscienceCompletedAutistic DisorderUnited States
-
University of Alabama at BirminghamCompletedInflammatory Bowel Diseases | Colorectal Cancer | Diverticular Diseases | Social BehaviorUnited States
-
Janssen Research & Development, LLCCompletedLupus Erythematosus, Systemic | Lupus Erythematosus, Cutaneous | Lupus Erythematosus, DiscoidUnited States, Poland
-
Hospital Universitario La Paz3MVX CCB and Agaplesion Markus Krankenhaus, Frankfurt a.M., Germany.; Department...RecruitingEmbolism | Atrial Fibrillation | Arrhythmia | Stroke, Acute | Stroke Sequelae | AblationSpain
-
Southern California College of Optometry at Marshall...Ohio State University; University of Houston; Alcon Research; University of Waterloo and other collaboratorsCompletedContact Lens Complication | Contact Lens Acute Red Eye | Contact Lens Related Corneal Infiltrate (Disorder) | Contact Lens-Induced Corneal Fluorescein StainingUnited States, Canada
-
Huashan HospitalZhejiang Cancer Hospital; Shanghai Zhongshan Hospital; Tongji Hospital; Qilu Hospital... and other collaboratorsRecruitingHead and Neck Squamous Cell Carcinoma | Patient Derived Organoid | Drug Sensitive Test in VitroChina
-
China Medical University HospitalUnknownIntention to Stay, Turnover Behavior
-
University of Dublin, Trinity CollegeCompleted